RPI ID: 2017-027-201

Innovation Summary:
This invention introduces a method for treating joint pain and inflammation using intra-articular injections of potassium-based compositions. The formulation includes potassium salts and other agents that modulate nerve activity and reduce pain signaling. It provides localized, long-lasting relief without systemic side effects. The treatment is designed for conditions such as osteoarthritis and rheumatoid arthritis.

Challenges / Opportunities:
Current treatments for joint pain often rely on systemic drugs or corticosteroid injections, which can have adverse effects. This invention offers a targeted, non-opioid alternative that directly addresses joint inflammation and pain. It opens opportunities for safer, more effective pain management in musculoskeletal disorders.

Key Benefits / Advantages:
✔ Localized treatment minimizes systemic exposure
✔ Non-opioid relief reduces reliance on addictive medications
✔ Long-lasting effect provides sustained pain reduction
✔ Safe and biocompatible formulation using naturally occurring ions

Applications:
• Osteoarthritis and rheumatoid arthritis
• Sports injuries and joint trauma
• Pain management clinics
• Orthopedic and rheumatology practices

Keywords:
#intraarticularinjection #potassiumtherapy #jointpainrelief #osteoarthritistreatment #nonopioidanalgesic

Intellectual Property:
US Issued Patent 11,406,612 B2